Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-25T09:40:36.945Z Has data issue: false hasContentIssue false
  • English
  • Français

Antibiotic prescribing during an outbreak of meningococcal disease

Published online by Cambridge University Press:  15 May 2009

J. M. Stuart ,
P. M. Robinson ,
K. Cartwright  and
N. D. Noah
J. M. Stuart
Affiliation:
Gloucester Health Authority, Rikenel, Montpellier, Gloucester GL1 1LY
P. M. Robinson
Affiliation:
Gloucester Health Authority, Rikenel, Montpellier, Gloucester GL1 1LY
K. Cartwright
Affiliation:
Public Health Laboratory, Gloucestershire Royal Hospital, Gloucester
N. D. Noah
Affiliation:
Kings College School of Medicine and Dentistry, London
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

During a prolonged outbreak of meningococcal disease caused by serogroup B serotype 15 sulphonamide-resistant strains in one British health district, there was considerable variation in attack rates by town. General practitioner (GP) antibiotic prescribing rates were compared in high and low incidence towns. The only significant difference found was that erythromycin prescribing was more frequent in the high incidence towns (rate ratio 4·0, 95% CI 3·2–4·8, in March 1987 and 3·0, 95% CI 2·4–3·7, in November 1987). This was probably due to increased GP consultation rates for upper respiratory tract infection (URTI), but higher erythromycin usage may have increased meningococcal acquisition rates or susceptibility to meningococcal disease. Antibiotic prescribing rate should be further investigated in defined areas of high and low incidence of meningococcal disease.

Type
Research Article
Information
Epidemiology & Infection , Volume 117 , Issue 1 , August 1996 , pp. 103 - 105
Copyright
Copyright © Cambridge University Press 1996

References

1.Cartwright, KAV, Stuart, JM, Noah, ND.An outbreak of meningococcal disease in Gloucestershire. Lancet 1986; ii: 558–61.CrossRefGoogle Scholar
2.Krasinski, K, Nelson, JD, Butler, S, Luby, JP, Kusmiez, H.Possible associations of mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol 1987; 125: 499–508.CrossRefGoogle ScholarPubMed
3.Moore, PS, Hierholzer, J, DeWitt, W, et al. Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA 1990; 264: 1271–5.CrossRefGoogle ScholarPubMed
4.Townsend, P, Davidson, N (eds). Inequalities in health. Harmondsworth, Middlesex: Penguin Books Ltd, 1982.Google Scholar
5.Filice, GA, Hayes, PS, Counts, GW, Griffiss, JM, Fraser, DW.Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora. J Clin Microbiol 1985; 22: 152–6.CrossRefGoogle Scholar
6.Olivares, R, Hubert, B.Clusters of meningococcal disease in France (1987–1988). Eur J Epidemiol 1992; 8: 737–42.CrossRefGoogle ScholarPubMed